Eurofins Scientific Crecimiento futuro
Future controles de criterios 3/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Eurofins Scientific de 18.3% y 7.3% por año respectivamente. Se prevé que el BPA crezca en un 17.9% al año. Se espera que la rentabilidad financiera sea de 11.4% en 3 años.
Información clave
18.3%
Tasa de crecimiento de los beneficios
17.9%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Life Sciences | 26.2% |
| Tasa de crecimiento de los ingresos | 7.3% |
| Rentabilidad financiera futura | 11.4% |
| Cobertura de analistas | Good |
| Última actualización | 13 Nov 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Results: Eurofins Scientific SE Beat Earnings Expectations And Analysts Now Have New Forecasts
Jul 27
Recent updates
Eurofins Scientific (EPA:ERF) Seems To Use Debt Quite Sensibly
Oct 21Earnings Tell The Story For Eurofins Scientific SE (EPA:ERF)
Aug 17Results: Eurofins Scientific SE Beat Earnings Expectations And Analysts Now Have New Forecasts
Jul 27These 4 Measures Indicate That Eurofins Scientific (EPA:ERF) Is Using Debt Extensively
May 10We Discuss Why Eurofins Scientific SE's (EPA:ERF) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year
Apr 19Eurofins Scientific SE's (EPA:ERF) Price In Tune With Earnings
Apr 18Does Eurofins Scientific (EPA:ERF) Have A Healthy Balance Sheet?
Nov 10Eurofins Scientific SE's (EPA:ERF) Intrinsic Value Is Potentially 64% Above Its Share Price
Oct 23We Think Eurofins Scientific (EPA:ERF) Is Taking Some Risk With Its Debt
Aug 07Are Investors Undervaluing Eurofins Scientific SE (EPA:ERF) By 25%?
Jul 20We Think Eurofins Scientific (EPA:ERF) Can Stay On Top Of Its Debt
May 03Eurofins Scientific SE (EPA:ERF) Shares Could Be 21% Above Their Intrinsic Value Estimate
Apr 11Estimating The Intrinsic Value Of Eurofins Scientific SE (EPA:ERF)
Jan 05Here's Why Eurofins Scientific (EPA:ERF) Can Manage Its Debt Responsibly
Dec 14An Intrinsic Calculation For Eurofins Scientific SE (EPA:ERF) Suggests It's 33% Undervalued
Oct 03Does Eurofins Scientific (EPA:ERF) Have A Healthy Balance Sheet?
Sep 06Eurofins Scientific (EPA:ERF) Is Increasing Its Dividend To €1.00
Jun 25Are Investors Undervaluing Eurofins Scientific SE (EPA:ERF) By 39%?
Jun 16Eurofins Scientific (EPA:ERF) Has A Rock Solid Balance Sheet
Jun 01Should You Be Adding Eurofins Scientific (EPA:ERF) To Your Watchlist Today?
Apr 12These 4 Measures Indicate That Eurofins Scientific (EPA:ERF) Is Using Debt Safely
Feb 25Is Eurofins Scientific SE (EPA:ERF) Worth €114 Based On Its Intrinsic Value?
Nov 28Eurofins Scientific (EPA:ERF) Has A Rock Solid Balance Sheet
Nov 14Here's Why I Think Eurofins Scientific (EPA:ERF) Might Deserve Your Attention Today
Sep 30Are Eurofins Scientific SE (EPA:ERF) Investors Paying Above The Intrinsic Value?
Aug 29We Think Eurofins Scientific (EPA:ERF) Can Manage Its Debt With Ease
Aug 15Do Eurofins Scientific's (EPA:ERF) Earnings Warrant Your Attention?
Jun 24Estimating The Fair Value Of Eurofins Scientific SE (EPA:ERF)
May 25Eurofins Scientific (EPA:ERF) Has A Rock Solid Balance Sheet
Mar 31Does Eurofins Scientific (EPA:ERF) Deserve A Spot On Your Watchlist?
Mar 17Eurofins Scientific SE (EPA:ERF) Has Got What It Takes To Be An Attractive Dividend Stock
Mar 03Eurofins Scientific SE Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Mar 03Are Institutions Heavily Invested In Eurofins Scientific SE's (EPA:ERF) Shares?
Feb 15
Is Eurofins Scientific's (EPA:ERF) 117% Share Price Increase Well Justified?
Dec 28Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2026 | 8,069 | 608 | 792 | 1,479 | 13 |
| 12/31/2025 | 7,500 | 506 | 679 | 1,339 | 14 |
| 12/31/2024 | 6,949 | 413 | 583 | 1,190 | 11 |
| 6/30/2024 | 6,724 | 326 | 674 | 1,215 | N/A |
| 3/31/2024 | 6,619 | 291 | 571 | 1,117 | N/A |
| 12/31/2023 | 6,515 | 257 | 468 | 1,018 | N/A |
| 9/30/2023 | 6,512 | 335 | 403 | 995 | N/A |
| 6/30/2023 | 6,510 | 414 | 339 | 971 | N/A |
| 3/31/2023 | 6,611 | 497 | 407 | 1,054 | N/A |
| 12/31/2022 | 6,712 | 581 | 476 | 1,136 | N/A |
| 9/30/2022 | 6,785 | 612 | 602 | 1,219 | N/A |
| 6/30/2022 | 6,857 | 643 | 727 | 1,301 | N/A |
| 3/31/2022 | 6,787 | 696 | 866 | 1,406 | N/A |
| 12/31/2021 | 6,718 | 749 | 1,005 | 1,511 | N/A |
| 9/30/2021 | 6,553 | 786 | 1,023 | 1,499 | N/A |
| 6/30/2021 | 6,388 | 824 | 1,041 | 1,487 | N/A |
| 3/31/2021 | 5,913 | 665 | 955 | 1,355 | N/A |
| 12/31/2020 | 5,439 | 505 | 868 | 1,224 | N/A |
| 9/30/2020 | 5,079 | 347 | 713 | 1,057 | N/A |
| 6/30/2020 | 4,719 | 190 | 558 | 891 | N/A |
| 3/31/2020 | 4,641 | 168 | 457 | 784 | N/A |
| 12/31/2019 | 4,563 | 146 | 355 | 678 | N/A |
| 9/30/2019 | 4,384 | 144 | 300 | 618 | N/A |
| 6/30/2019 | 4,205 | 143 | 244 | 558 | N/A |
| 3/31/2019 | 3,993 | 159 | 212 | 551 | N/A |
| 12/31/2018 | 3,781 | 175 | 180 | 544 | N/A |
| 9/30/2018 | 3,549 | 182 | 179 | 521 | N/A |
| 6/30/2018 | 3,318 | 190 | 178 | 498 | N/A |
| 3/31/2018 | 3,145 | 185 | N/A | 451 | N/A |
| 12/31/2017 | 2,971 | 179 | N/A | 405 | N/A |
| 9/30/2017 | 2,848 | 166 | N/A | 387 | N/A |
| 6/30/2017 | 2,725 | 152 | N/A | 369 | N/A |
| 3/31/2017 | 2,631 | 145 | N/A | 370 | N/A |
| 12/31/2016 | 2,537 | 138 | N/A | 372 | N/A |
| 9/30/2016 | 2,427 | 104 | N/A | 350 | N/A |
| 6/30/2016 | 2,317 | 69 | N/A | 328 | N/A |
| 3/31/2016 | 2,133 | 63 | N/A | 310 | N/A |
| 12/31/2015 | 1,950 | 56 | N/A | 291 | N/A |
| 9/30/2015 | 1,779 | 71 | N/A | 274 | N/A |
| 6/30/2015 | 1,609 | 86 | N/A | 256 | N/A |
| 3/31/2015 | 1,509 | 82 | N/A | 234 | N/A |
| 12/31/2014 | 1,410 | 78 | N/A | 212 | N/A |
| 9/30/2014 | 1,355 | 66 | N/A | 187 | N/A |
| 6/30/2014 | 1,299 | 53 | N/A | 162 | N/A |
| 3/31/2014 | 1,262 | 53 | N/A | 166 | N/A |
| 12/31/2013 | 1,226 | 53 | N/A | 169 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (18.3% al año) de ERF es superior a la tasa de ahorro (1.4%).
Beneficios vs. Mercado: Se prevé que los beneficios (18.3% al año) de ERF crezcan más rápidamente que el mercado French (12.5% al año).
Beneficios de alto crecimiento: Se prevé que los beneficios de ERF crezcan, pero no significativamente.
Ingresos vs. Mercado: Se prevé que los ingresos (7.3% al año) de ERF crezcan más rápidamente que los del mercado French (5.6% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 7.3% al año) de ERF crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de ERF sea baja dentro de 3 años (11.4%).